Volitionrx (VNRX) EBITDA Margin Growth (1y) (2020 - 2025)
Volitionrx (VNRX) EBITDA Margin Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -313.00 |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 241.00 |
| 10 | Volitionrx | 92,593.09 | -1.02 Mn | - | 351,916.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 351,916.00 |
| Sep 30, 2025 | 63,199.00 |
| Jun 30, 2025 | -7,228.00 |
| Mar 31, 2025 | 273,201.00 |
| Dec 31, 2024 | 817,194.00 |
| Sep 30, 2024 | 534,030.00 |
| Jun 30, 2024 | 191,532.00 |
| Mar 31, 2024 | 128,851.00 |
| Dec 31, 2023 | -2.10 Mn |
| Sep 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 46,013.00 |
| Dec 31, 2022 | 6.96 Mn |
| Sep 30, 2022 | -1.04 Mn |
| Jun 30, 2022 | 343,524.00 |
| Mar 31, 2022 | 1.71 Mn |
| Dec 31, 2021 | 1.78 Mn |
| Sep 30, 2021 | 75.37 Mn |
| Jun 30, 2021 | 7.65 Mn |
| Mar 31, 2021 | 105.56 Mn |